Información del artículo
El Texto completo está disponible en PDF
Biblografía
[1.]
S.J. Silverberg, J.P. Bilezikian, H.G. Bone, G.B. Talpos, M.J. Horwitz, A.F. Stewart.
Therapeutic controversies in primary hyperparathyroidism.
J Clin Endocrinol Metab, 84 (1999), pp. 2275-2285
[2.]
S. Hassani, G.D. Braunstein, M.J. Seibel, A.S. Brickman, F. Geola, A.E. Pekary, et al.
Alendronate therapy of primary hyperparathyroidism.
Endocrinologist, 11 (2001), pp. 459-464
[3.]
S.J. Silverberg, E. Shane, T.P. Jacobs, E. Siris, J.P. Bilezikian.
A 10-year prospective study of primary hyperparathyroidism with and without parathyroid surgery.
N Engl J Med, 341 (1999), pp. 1249-1255
[4.]
M. Rossini, D. Gatti, G. Isaia, L. Sartori, V. Braga, S. Adami.
Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.
J Bone Min Res, 16 (2001), pp. 113-119
[5.]
A.A. Khan, J.P. Bilezikian, A.W. Kung, M.M. Ahmed, S.J. Dubois, A.Y.Y. Ho, et al.
A double blind randomized placebo controlled trial of alendronate in primary hyperparathyroidism.
J Bone Min Res, 16 (2001), pp. 226
[6.]
T. Horiuchi, T. Onouchi, J. Inoue, A. Shionoiri, T. Hosoi, H. Orimo.
A strategy for the management of elderly women with primary hyperparathyroidism: a comparison of etidronate therapy with parathyroidectomy.
Gerontology, 48 (2002), pp. 103-108
[7.]
J.E. Mulder, J.P. Bilezikian.
Acute management of hypercalcemia.
2nd ed The parathyroids. Basic and clinical aspects, pp. 729
[8.]
C.A. Reasner, M.D. Stone, D.J. Hosking, A. Ballah, G.R. Mundy.
Acute changes in calcium homeostasis during treatment of primary hyperparathyroidism with risedronate.
J Clin Endocrinol Metab, 77 (1993), pp. 1067-1071
[9.]
A.B. Grey, J.P. Stapelton, M.C. Evans, M.A. Tatnell, I. Reid.
Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial.
Ann Intern Med, 125 (1996), pp. 360-368
[10.]
B.J. Orr-Walker, M.C. Evans, J.M. Clearwater, A. Horne, A.B. Grey, I.R. Reid.
Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism.
Arch Intern Med, 160 (2000), pp. 2161-2166
[11.]
C.Y. Guo, W.E.G. Thomas, A.W. Al-Dehaimi, A.M.A. Assiri, R. Eastell.
Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism.
J Clin Endocrinol Metab, 81 (1996), pp. 3487-3491
Copyright © 2002. Sociedad Española de Endocrinología y Nutrición
